Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund
Plus news about Frazier Life Sciences, BigHat Biosciences, Kasvu Therapeutics, Arcturus Therapeutics, Oruka Therapeutics and Viking Therapeutics.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







